SHIARA VASSIAN: Open Payments
NPI 1487763355 · COVINGTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$365 in 18 payments from 9 companies in 2025. Trend: 2023 $377 · 2024 $718 · 2025 $365
Food & beverage: $365
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $89 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| PFIZER INC. | 3 | $47 |
| Organon LLC | 2 | $44 |
| Janssen Biotech, Inc. | 2 | $38 |
| UCB, Inc. | 2 | $37 |
| Lilly USA, LLC | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: RINVOQ, DUPIXENT, CIBINQO, TREMFYA, Bimzelx, SKYRIZI, EBGLYSS, VTAMA.
Industry payments across GA — which companies pay providers there.
